Machalek Dorothy A, Jin Fengyi, Poynten I Mary, Hillman Richard J, Templeton David J, Law Carmella, Roberts Jennifer M, Tabrizi Sepehr N, Garland Suzanne M, Farnsworth Annabelle, Fairley Christopher K, Grulich Andrew E
HIV Epidemiology and Prevention Program, The Kirby Institute for infection and immunity in society, University of New South Wales, Sydney, Australia; Department of Microbiology and Infectious Diseases, Royal Women's Hospital and Murdoch Childrens Research Institute, Melbourne, Australia.
HIV Epidemiology and Prevention Program, The Kirby Institute for infection and immunity in society, University of New South Wales, Sydney, Australia.
Papillomavirus Res. 2016 Dec;2:97-105. doi: 10.1016/j.pvr.2016.05.003. Epub 2016 May 24.
Anal intraepithelial neoplasia grade 2 (AIN2) and AIN grade 3 (AIN3) are commonly grouped together as high grade squamous intraepithelial lesions (HSIL). We assessed risk factors for HSIL-AIN2 and HSIL-AIN3 in a cohort of homosexual men.
At the baseline visit in the Study for the Prevention of Anal Cancer (SPANC), all men completed a questionnaire and underwent anal swabbing for cytology and HPV genotyping, followed by high resolution anoscopy.
Composite-HSIL prevalence was 47% and 32% among 220 HIV-positive and 396 HIV-negative men, respectively. HSIL-AIN3 (37.7% versus 24.7%; p<0.001), but not HSIL-AIN2 (9.5% versus 7.6%; p=0.395) was more common in HIV-positive men. Recent receptive anal partners (p-trend=0.045), and increasing number of high-risk (HR)-HPV types (p-trend<0.001) were associated with HSIL-AIN2. Lifetime receptive partners (p-trend<0.001), HIV status (OR 1.74; 95% CI: 1.05-2.87) and HPV16 (OR 3.00; 95% CI: 1.56-5.75) were associated with HSIL-AIN3. HPV16 was the most common HR-HPV type detected in men with HSIL-AIN3, both HIV-negative (61.1%) and HIV-positive (54.9%). HPV16 was less commonly detected in men with HSIL-AIN2.
Grouping HSIL-AIN2 and HSIL-AIN3 as HSIL may mask considerable heterogeneity in anal cancer risk. Given the strong link between HPV16 and anal cancer, men with HSIL-AIN3 and HPV16 are likely to be at greatest risk of cancer.
肛管上皮内瘤变2级(AIN2)和肛管上皮内瘤变3级(AIN3)通常归为高级别鳞状上皮内病变(HSIL)。我们在一组男同性恋者中评估了HSIL-AIN2和HSIL-AIN3的危险因素。
在肛管癌预防研究(SPANC)的基线访视时,所有男性均完成问卷调查,并接受肛管拭子检查以进行细胞学检查和HPV基因分型,随后进行高分辨率肛门镜检查。
在220名HIV阳性男性和396名HIV阴性男性中,复合性HSIL患病率分别为47%和32%。HSIL-AIN3在HIV阳性男性中更常见(37.7%对24.7%;p<0.001),但HSIL-AIN2并非如此(9.5%对7.6%;p=0.395)。近期接受肛交的性伴侣(p趋势=0.045)以及高危(HR)-HPV类型数量增加(p趋势<0.001)与HSIL-AIN2相关。终身接受肛交的性伴侣数量(p趋势<0.001)、HIV状态(比值比1.74;95%置信区间:1.05-2.87)和HPV16(比值比3.00;95%置信区间:1.56-5.75)与HSIL-AIN3相关。HPV16是在HSIL-AIN3男性中检测到的最常见的HR-HPV类型,在HIV阴性(61.1%)和HIV阳性(54.9%)男性中均如此。在HSIL-AIN2男性中较少检测到HPV16。
将HSIL-AIN2和HSIL-AIN3归为HSIL可能掩盖肛管癌风险中相当大的异质性。鉴于HPV16与肛管癌之间的紧密联系,患有HSIL-AIN3和HPV16的男性患癌风险可能最大。